Roche Molecular Systems Controller Salary | Comparably
Roche Molecular Systems, Inc., a molecular diagnostics company, develops and commercializes diagnostic and blood screening tests based on read more
EMPLOYEE
PARTICIPANTS
15
TOTAL
RATINGS
176

Roche Molecular Systems Controller Salary

The average Roche Molecular Systems Controller earns an estimated $141,740 annually. Roche Molecular Systems' Controller compensation is $18,461 more than the US average for a Controller.

The Finance Department at Roche Molecular Systems earns $254 more on average than the Customer Support Department.

Last updated a year ago.

$47k
$71k
$95k
$118k
$180k
$240k
$300k
$141,740
Average Compensation
$141,740
avg. base

Controller Salaries at Roche Molecular Systems

Controllers earn $24,343 more than Financial Analysts, and $1,189 less than Accounting Managers.

Accounting Manager
$143k*
Financial Analyst
$117k*
Business Analyst
$115k*
Senior Accountant
$106k*
Accountant
$87k*
* estimated salary

Compensation at Roche Molecular Systems by Department

The Finance Department averages $254 more than the Customer Support Department, and $11,108 less than the IT Department

IT
$113,023 Avg. total comp.
+$11k
Finance
$101,915 Avg. total comp.
Customer Support
$101,661 Avg. total comp.
-$254

Controller Compensation by Gender (All Companies)

The average female Controller at companies similar size to Roche Molecular Systems reported making $138,290, while the average male Controller at similar sized companies reported making $133,282.

Controller Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Controller at companies similar size to Roche Molecular Systems reported making $132,409, while the average Caucasian Controller at similar sized companies reported making $129,306.

How Controllers at Roche Molecular Systems Rate Their Compensation

The majority of Controllers at Roche Molecular Systems believe they're compensated fairly. 100% of Controllers at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems

×
Rate your company